9969 — InnoCare Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual income statement for InnoCare Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1.25	1.36	1,043	625	739
Cost of Revenue
Gross Profit	1.25	1.36	977	482	610
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,152	392	1,064	1,519	1,390
Operating Profit	-2,151	-391	-21.5	-893	-651
Other Net Non Operating Costs
Net Income Before Taxes	-2,150	-392	-20.1	-894	-644
Provision for Income Taxes
Net Income After Taxes	-2,150	-392	-66.7	-894	-646
Minority Interest
Net Income Before Extraordinary Items
Net Income	-2,141	-391	-64.5	-887	-631
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-2,141	-391	-64.5	-887	-631
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.21	-0.222	-0.037	-0.503	-0.37
Dividends per Share